tiprankstipranks
Trending News
More News >
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market

AN2 Therapeutics, Inc. (ANTX) Cash flow

Compare
94 Followers

AN2 Therapeutics, Inc. Cash Flow

ANTX's free cash flow for Q3 2025 was $-6.38M. For the 2025 fiscal year, ANTX's free cash flow was decreased by $4.03M and operating cash flow was $-6.38M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -49.26M$ -53.29M$ -33.46M$ -20.48M$ -5.36M
Investing Cash Flow
$ 54.59M$ -43.28M$ -21.77M$ -50.02M$ 0.00
Financing Cash Flow
$ 372.00K$ 84.99M$ 70.36M$ 78.53M$ 3.84M
End Cash Position
$ 21.35M$ 15.65M$ 27.22M$ 12.10M$ 4.07M
Free Cash Flow
$ -49.26M$ -53.29M$ -33.46M$ -20.48M$ -5.36M
Currency in USD

AN2 Therapeutics, Inc. Cash Flow